Unique Missions Of FDA, CMS Underscored In Presentations To HHS Panel

Ongoing attempts to coordinate FDA and CMS reviews will preserve approval, coverage, coding and payment as distinct processes, agency representatives concurred at the HHS Secretary's Advisory Committee on Regulatory Reform regional hearing June 10

More from Archive

More from Medtech Insight